A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer

Por Zelek, L, Yovine, A, Brain, E, Turpin, F, Taamma, A, Riofrio, M, Spielmann, M, Jimeno, J, Misset, J L
Publicado em 2006

P17.64 ANGIOGENIC AND PROCOAGULANT FACTORS IN PLASMA OF BRAIN TUMOUR PATIENTS TREATED WITH BEVACIZUMAB

Por Pace, A., Antenucci, A., Mandoj, C., Villani, V., Carapella, C.M., Fabi, A., Conti, L.
Publicado em 2014

Treatment for children with brain tumours.

Por Stevens, M. C., Hockley, A. D., Spooner, D., Walsh, A. R.
Publicado em 1995

Use of high dose corticosteroids in patients with inoperable brain tumours.

Por Lieberman, A, LeBrun, Y, Glass, P, Goodgold, A, Lux, W, Wise, A, Ransohoff, J
Publicado em 1977

Incidence and long-term survival of children with intracranial tumours treated in Denmark 1935-1959

Por Gjerris, F., Harmsen, A., Klinken, L., Reske-Nielsen, E.
Publicado em 1978

Brain tumour post-treatment imaging and treatment-related complications

Por Kessler, Alexander T., Bhatt, Alok A.
Publicado no Insights Imaging (2018)

Focal chemotherapy of brain tumours using semipermeable membranes.

Por Wilkinson, H A, Kornblith, P, Weems, S
Publicado em 1977

Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours.

Por Livesey, E A, Brook, C G
Publicado em 1989

Are we over treating Pineal Parenchymal tumour with intermediate differentiation? Assessing the role of localised radiation therapy and literature review

Por Das, P., Mckinstry, S., Devadass, A., Herron, B., Conkey, D. S.
Publicado no Springerplus (2016)

Multiprofessional follow‐up programmes are needed to address psychosocial, neurocognitive and educational issues in children with brain tumours

Por van't Hooft, I, Lindahl Norberg, A, Björklund, A, Lönnerblad, M, Strömberg, B
Publicado no Acta Paediatr (2015)

P12 A PHASE I TRIAL OF INTRAVENOUS ONCOLYTIC REOLYSIN(®) IN PATIENTS WITH BRAIN TUMOURS

Por Jebar, A., West, E., Scott, K., Thomson, S., Corns, R., Mathew, R., SivaKumar, G., Coffey, M., Nuovo, G., Rose, A., Ralph, C., Twelves, C., Anthoney, A., Griffin, S., Short, S., Melcher, A.
Publicado em 2014

Endocrine disorders following treatment of childhood brain tumours.

Por Livesey, E. A., Hindmarsh, P. C., Brook, C. G., Whitton, A. C., Bloom, H. J., Tobias, J. S., Godlee, J. N., Britton, J.
Publicado em 1990

Treatment and outcome of patients with extragonadal germ cell tumours--the Norwegian Radium Hospital's experience 1979-94.

Por Dueland, S., Stenwig, A. E., Heilo, A., Høie, J., Ous, S., Fosså, S. D.
Publicado em 1998

ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice

Por Perotti, C, Casas, A, Fukuda, H, Sacca, P, Batlle, A
Publicado em 2002

Fractionated stereotactic radiation therapy for brain metastases: a systematic review with tumour control probability modelling

Por Baliga, Sujith, Garg, Madhur K, Fox, Jana, Kalnicki, Shalom, Lasala, Patrick A, Welch, Mary R, Tomé, Wolfgang A, Ohri, Nitin
Publicado no Br J Radiol (2017)

Analysis of clonogenic human brain tumour cells: preliminary results of tumour sensitivity testing with BCNU.

Por Rosenblum, M. L., Dougherty, D. A., Deen, D. F., Hoshino, T., Wilson, C. B.
Publicado em 1980

Gonadal dysfunction after treatment of intracranial tumours.

Por Livesey, E A, Brook, C G
Publicado em 1988

Is cell survival a determinant of the in situ response of 9L tumours?

Por Wheeler, K. T., Wallen, C. A.
Publicado em 1980

Growth impairment in children treated for brain tumours.

Por Shalet, S M, Beardwell, C G, Aarons, B M, Pearson, D, Jones, P H
Publicado em 1978

P07.12 Multimodal imaging of the invasive microenvironment predicts survival in glioblastomas

Por Price, S. J., Boonzaier, N. R., Yan, J., McLean, M. A.
Publicado no Neuro Oncol (2016)